Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKBC.L Regulatory News (KBC)

  • There is currently no data for KBC

Pre-close Trading Update

12 Jan 2012 07:00

RNS Number : 4198V
KBC Advanced Technologies plc
12 January 2012
 



 

 

 

12 January 2012

 

KBC Advanced Technologies plc

("KBC" or "the Group")

 

Pre-close Trading Update

 

In 2011 KBC delivered strong growth in consulting revenues and as a result our forecast for the year ended 31 December 2011 is broadly in line with our expectations, delivering over 20% profits growth in the period.

 

The largest single item contributing to the increase in consulting activity is the US$42m Profit Improvement Program with Pemex Refinación. Work at all six sites is now under way and the project will continue at what is now the peak activity level until the third quarter of 2012. A number of other projects are contributing to high utilisation. These include Reliance Industries in India, Bashneft in Russia, Total in Europe and several gas projects in Australasia. Despite the Arab Spring, the tsunami in Japan and the weak European refining market, we expect consulting revenue for the year as a whole to be the highest since 2008.

 

The negotiation of several software license sales have extended into 2012 from the last quarter of 2011 and we therefore expect a healthy level of software sales in the first half of 2012. With the arbitration process now behind us, we look forward to being able to fully realise the potential of our software products and services across all of the markets that we serve in 2012 and beyond.

 

Following strong cash generation in the second half of the year, the Group's net cash position is expected to be around £5.5m at the year end, up from the £2.6m held at 30 June 2011. The comparable figure at 31 December 2010 was £4.5m. Our workload backlog at the year end is expected to be around £49m.

 

As we start 2012 our consulting resources are highly utilised in each of our three operating regions. The refining industry is still in a state of transition, with markedly varying economic drivers in different parts of the world that have intensified in recent months, and should continue to provide consulting opportunities. Other markets in which we operate, such as petrochemicals and gas processing, remain stronger than refining and will also provide additional opportunities in 2012. We therefore look forward to the coming year confident that KBC will continue to deliver a strong trading performance.

 

 

-Ends-

 

KBC Advanced Technologies plc

George Bright, Chief Executive

Nicholas Stone, Operations and Finance Director

01932 236314

 

 

 

 

Weber Shandwick Financial

Nick Oborne/Stephanie Badjonat

020 7067 0727

Cenkos Securities plc

Jon Fitzpatrick

Neil McDonald

020 7397 8900

0131 220 9771

 

 

 

 

 

About KBC:

 

For 30 years KBC's consultants have provided independent strategic and engineering expertise to enable leading companies in the global energy business and other process industries to manage risk while maximising value from their assets.

 

In times of economic uncertainty and increasing environmental pressure, KBC's proprietary methodologies and innovative tools guide its clients' key strategic decisions, enabling them to prioritise and implement initiatives that maximise return on investment, and improve operational performance. KBC offers Strategic and Market, Capital Investment, Operating, Organisational and Environmental Solutions.

 

For more information, visit www.kbcat.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUASWRUUAAAAR
Date   Source Headline
28th Mar 20139:56 amRNSDirector/PDMR Shareholding
26th Mar 20137:00 amRNSFinal Results
8th Mar 201310:45 amRNSNotice of Results
4th Feb 20132:41 pmRNSTotal Voting Rights
28th Jan 20139:55 amRNSDirector/PDMR Shareholding
28th Jan 20139:22 amRNSHolding(s) in Company
28th Jan 20139:17 amRNSHolding(s) in Company
25th Jan 201311:39 amRNSDirector/PDMR Shareholding
24th Jan 20137:00 amRNSPre-close Trading Update
8th Jan 20132:52 pmRNSHolding(s) in Company
27th Dec 201211:08 amRNSDirector/PDMR Shareholding
21st Dec 201211:38 amRNSDirector/PDMR Shareholding
19th Dec 20127:00 amRNSUS$100 million Contract Award
3rd Dec 20129:31 amRNSTotal Voting Rights
25th Oct 201210:44 amRNSDirector/PDMR Shareholding
23rd Oct 201212:40 pmRNSDirector/PDMR Shareholding
16th Oct 20128:56 amRNSHolding(s) in Company
15th Oct 20129:29 amRNSDirector/PDMR Shareholding
10th Oct 201210:45 amRNSHolding(s) in Company
10th Oct 20129:21 amRNSDirector/PDMR Shareholding
9th Oct 20122:04 pmRNSBlocklisting Interim Review
9th Oct 20129:39 amRNSHolding(s) in Company
8th Oct 201212:21 pmRNSDirector/PDMR Shareholding
5th Oct 20127:00 amRNSBoard Changes
2nd Oct 20124:04 pmRNSCompletion of cash subscription
28th Sep 20122:56 pmRNSHolding(s) in Company
28th Sep 201210:41 amRNSDirector/PDMR Shareholding
26th Sep 20127:00 amRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSHalf Year Results and Cash Subscription
20th Sep 20127:00 amRNSAppointment of Director & Chief Financial Officer
12th Sep 20123:30 pmRNSNotice of Results
13th Aug 201210:57 amRNSHolding(s) in Company
1st Aug 20129:18 amRNSTotal Voting Rights
24th Jul 20127:00 amRNSTrading Update and Confirmation of Board Changes
18th Jul 201210:00 amRNSHolding(s) in Company
2nd Jul 20123:44 pmRNSTotal Voting Rights
21st Jun 20127:00 amRNSDirector/PDMR Shareholding
19th Jun 20127:00 amRNSAcquisition of Infochem
31st May 20123:39 pmRNSTotal Voting Rights
9th May 20124:56 pmRNSAGM Statement
9th May 20127:00 amRNSAGM Statement
1st May 201211:50 amRNSTotal Voting Rights
11th Apr 20124:58 pmRNSBlocklisting Interim Review
11th Apr 20124:48 pmRNSBlocklisting Interim Review
10th Apr 201210:00 amRNSAnnual Financial Report
13th Mar 20127:00 amRNSFinal Results
5th Mar 20124:00 pmRNSNotice of Results
2nd Feb 201210:21 amRNSTotal Voting Rights
23rd Jan 20121:42 pmRNSHolding(s) in Company
16th Jan 20129:41 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.